New insights into immune response with coronavirus vaccine candidate SolaVAX
The vaccine candidate helped minimize changes in tissues in the lungs caused by SARS-CoV-2.
Tag: "Department of Microbiology Immunology and Pathology"
CSU vaccine research advances, groundwork begins to develop coronavirus vaccine for the next pandemic
Researchers aim to create a vaccine candidate that would protect people from a spectrum of coronaviruses.
CSU delivers COVID wastewater testing data to state health officials and wastewater partners
Health officials can immediately access this timely data through a dashboard created by CSU.
CSU researchers identify promising model for studying human aging
Researchers will use the translational model to study interventions to prevent or slow the decline in overall musculoskeletal function with aging in humans.
Studying the course of infection: Colorado State University teams up with UCHealth for COVID-19 biobank, research
The goal of the research is to identify and follow the course of infection in people for at least six months.
Five research teams selected for Catalyst for Innovative Partnership funding
The teams were selected from a competitive pool of applicants to pursue significant issues in our society using research partnerships to create new opportunities and solutions.
Microbiology professor honored for trimming costs for students
Medora Huseby was honored by Gov. Polis for making textbooks and learning materials affordable for students through use of open educational resources.
CSU scientists work to curb the spread of COVID-19 with targeted testing
The strategy relies on quick identification and isolation of individuals on campus infected with coronavirus.
Older people like President Trump are at more risk from COVID-19 because of how the immune system ages
At 74 years old, Trump is solidly within an age group that’s been hit hard during the coronavirus pandemic.
CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research
Researchers at CSU have worked quickly and collaboratively to move this vaccine research forward.